Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, ...

More than a decade after the first Neanderthal genome was sequenced, scientists are still working to understand how human-specific DNA changes shaped human evolution. It's just over a decade since ...

Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...

The MarketWatch News Department was not involved in the creation of this content. Targeting the Root Causes of Aging Demonstrates Powerful Anti-Cancer Activity Across Multiple Tumor Models MIAMI BEACH ...

Mercedes tried a bit too hard to make the EQE stand out from the ICE-powered E-Class, to the point where not many people would say that it is a good-looking ride. Far from it, actually, as the ...

An illustration of a protein created by Accipiter Bio that has two active sites, shown in light and darker green, that can simultaneously bind two targets. (Accipiter Bio Image) A Seattle biotech ...

Raise your glasses high, because Vanderpump Rules Season 12's all-new cast of SUR-vers are ready for a shift change. The new group is a "deep-rooted, dynamic group of friends, frenemies, and lovers ...

No prescription is required for the "double dose of drama and shade" ahead on Married to Medicine Season 12. Dispensing the medical-grade reads are returning cast members Dr. Jackie Walters, Dr.

San Diego-based Dexcom Inc., is the target of a class action lawsuit in U.S. district court over the company’s G7 continuous glucose monitors, an action which follows a U.S. FDA warning letter by a ...

All products and listings featured on Condé Nast Traveler are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these ...

ITHACA, N.Y.--(BUSINESS WIRE)--Ascribe Bio (“Ascribe”), an innovator in natural crop protection, today announced the closing of an oversubscribed $12 million Series A financing round, co-led by ...

Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...